Jump Financial »

Diamedica Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $90k 11k 7.96
2021-12-31 $81k 22k 3.72
2021-09-30 $73k 18k 3.99

More positions owned by Jump Financial

iShares Russell 2000 ETF Etf (IWM)
SPDR S&P 500 ETF Trust Etf Call Option (SPY)
iShares 20 Year Treasury Bond ETF Etf (TLT)
NVIDIA Corp Common Stock (NVDA)
Walmart Common Stock (WMT)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
iShares iBoxx $ High Yield Corporate Bond ETF Etf (HYG)
Alphabet Common Stock (GOOGL)
Advanced Micro Devices Common Stock (AMD)
Netflix Common Stock (NFLX)
Palantir Technologies Common Stock (PLTR)
Alibaba Group Holding Convertible bond (Principal)
Boston Scientific Corp Common Stock (BSX)
Energy Transfer Partnership Shares (ET)

View all positions for Jump Financial

Top funds holding Diamedica Therapeutics

Omega Advisors
BlackRock
Millennium Management
Paragon Associates & Paragon Associates Ii Joint Venture
Geode Capital Management
Vanguard Group
State Street Corporation
First Manhattan
Bleichroeder
Northern Trust
Advisor Group Holdings
LPL Financial
Goldman Sachs Group
Bank of New York Mellon
Nuveen

View all funds holding Diamedica Therapeutics